Pages

Thursday, November 20, 2014

Regeneron and Sanofi Announce that Dupilumab Has Received FDA...

... Pharmaceuticals, Inc. Regeneron (NASDAQ: REGN ) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical ...

http://ift.tt/1uUPxq2

No comments:

Post a Comment